Defining Biopharma Dealmaking Success: An Analysis Of 2003 Alliances
Executive Summary
This article examines the question do external biopharma programs succeed at similar rates as internal projects? IN VIVO examined this question by analyzing the alliances of 2003, mining both Elsevier's Strategic Transactions database and SEC documents, and bolstering these data with independent reporting.